MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Dysregulated Anti-Viral Response in LRRK2 Mice Following Infection with H1N1 Influenza Induces DA Neuron Loss in the SNpc.

    K. Crowther, R. Smeyne, E. Kozina (Philadelphia, USA)

    Objective: In this study, we sought to determine if there is a synergistic effect of non-neurotropic H1N1 influenza and the G2019S LRRK2 mutation associated Parkinson’s…
  • 2024 International Congress

    Safety and Tolerability of Ecopipam in Tourette Syndrome (TS) with Psychiatric Comorbidities.

    D. Gilbert, S. Atkinson, G. Karkanias, R. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)

    Objective: Evaluate the effect of ecopipam in children and adolescents with TS on measures of attention deficit disorder (ADHD), anxiety disorders (ANX), obsessive-compulsive disorder (OCD)…
  • 2024 International Congress

    SAGE-324/BIIB124, an investigational GABAA receptor PAM, for treatment of essential tremor

    P. Lewitt, H. Jinnah, R. Pahwa, A. Ellenbogen, R. Kumar, TM. Lieu, B. Hersh, R. Chuang, C. Vaudreuil, Z. Berger, D. Arkilo, SH. Kuo (Bloomfield, USA)

    Objective: KINETIC2 is a multicenter, randomized, placebo-controlled, dose-response Ph2b study evaluating SAGE-324/BIIB124 for treatment of essential tremor (ET). Background: ET is a common movement disorder1,2…
  • 2024 International Congress

    Palliative and end-of-life care in Parkinson’s disease : French patients’ perceptions and knowledge

    M. Auffret, L. Cronier, G. Robert, M. Béreau, M. Giffard, M. Vérin (Rennes, France)

    Objective: (1) Assess patients' perceptions and knowledge of palliative and end-of-life care in PD; (2) evaluate (i) whether patients discuss these topics with healthcare professionals and/or…
  • 2024 International Congress

    Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

    E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to explore the therapeutic target for Lewy body disease. Background: Lewy body disease (LBD), including Parkinson's disease and diffuse Lewy…
  • 2024 International Congress

    Melatonin Modulates NLRP3 Inflammasome Activation through TLR2 to Protect Against Parkinson’s Disease

    XY. Wang, JW. Li, HS. Liu, XN. Xiong (Wuhan, China)

    Objective: This study aims to investigate the impact of MLT on inflammation signaling pathway mediated by TLR2 in α-synuclein (α-syn) overexpressed BV2 cells and PD…
  • 2024 International Congress

    Differences in Molecular and Ultrastructural profiles of astroglia and microglia in substantia nigra of two different mice strains in normal aging and experimental Parkinsonism

    P. Alladi, A. Abhilash, U. Bharti, R. Santhosh Kumar, M. Philip, B. Chandrasekhar Sagar (Bangalore, India)

    Objective: To examine whether the variable sensitivity of dopaminergic neurons of the substantia nigra pars compacta -SNpc- in C57BL/6J and CD-1 mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/ MPTP…
  • 2024 International Congress

    The Impact of VPS35 D620N Mutation on Alternative Autophagy and its Reversal by Estrogen in Parkinson’s Disease

    T. Shiraishi, K. Bono, Y. Iguchi, H. Okano (Minato-ku, Japan)

    Objective: We investigated the relationship between alternative autophagy and VPS35 D620N mutant-related PD pathogenesis. Background: VPS35 is critically involved in the mechanisms of neurodegeneration observed…
  • 2024 International Congress

    Differential Symptom Cluster Responses and Predictors to Repetitive Transcranial Magnetic Stimulation Treatment in Parkinson’s Disease:A Retrospective Study

    J. Sun, P. Hu (hefei, China)

    Objective: This study aimed to investigate the related factors for the response to rTMS in PD patients. Background: Repetitive transcranial magnetic stimulation (rTMS) is an…
  • 2024 International Congress

    SNCA Antisense Oligonucleotide for Multiple System Atrophy: HORIZON Trial Update

    K. Meilleur, K. Seppi, F. Krismer, R. Simoes, T. Lampreia, J. Corvol, S. Sambin, G. Hoglinger, C. Schindler, A. Schnitzler, C. Hartmann, K. Eggert, H. Pape, A. Ludolph, J. Kassubek, O. Rascol, M. Rumbel, D. Schulz, S. Darrow, Y. Deng, P. Gupta, S. Stanton, J. Esteban, H. Zhao, M. Yarborough, R. Fong (Carlsbad, USA)

    Objective: To provide an update on the baseline demographics and safety from the HORIZON Clinical Trial of ION464 Background: Multiple System Atrophy (MSA) is a…
  • « Previous Page
  • 1
  • …
  • 319
  • 320
  • 321
  • 322
  • 323
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley